Legal Proceedings Report • Apr 29, 2024
Legal Proceedings Report
Open in ViewerOpens in native device viewer
Disclosure 445860
Optomed PlcStock Exchange Release29 April 2024 at 13:20, Helsinki No updates on the Optomed Aurora AEYE FDA clearance process Optomed is together with its partner AEYE Health in the process of obtaining a clearance for the AI fundus camera Optomed Aurora AEYE. At this stage, Optomed does not have any new information regarding the FDA clearance process. Optomed will update market as new information becomes available. Optomed Plc Further enquiries Juho Himberg, CEO, [email protected] Optomed in Brief Optomed is a Finnish medical technology company and a leading manufacturer of handheld fundus cameras and screening software. Optomed combines handheld fundus cameras with software and artificial intelligence with the aim to transform the diagnostic process of various diseases, such as rapidly increasing diabetic retinopathy. Optomed has offices in Finland, the US and China and the company's products are sold via various sales channels in over 60 countries globally www.optomed.com
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.